Genesis Protect availability
Start here if
Use this page before describing, selling, integrating, or reviewing Genesis Protect Acute.
Current public boundary
Genesis Protect Acute is on a bounded mainnet launch target.
It is not broadly available insurance today.
What is true now
Travel 30is the primary launch SKU.Event 7is the fast demo SKU.- Product terms, evidence requirements, and reserve-lane wording are published.
- Phase 0 claim review is operator-backed.
- Protection issuance depends on posted reserve, staffed review operations, and published metadata staying aligned.
What this page does not claim
- It does not claim broad always-on public issuance today.
- It does not claim fully decentralized claim review today.
- It does not claim that app membership fees are claims-paying reserve.
- It does not claim that unposted demand, future yield, or narrative momentum count as reserve.
- It does not claim that a product can stay open after reserve, staffing, schema, pricing, or benefit truth drifts from the published launch posture.
Issuance gates
| Gate | Travel 30 | Event 7 |
|---|---|---|
| Posted reserve | Travel 30 premium and liquidity lanes must support the marketed issuance window. | Event 7 premium, sponsor, or liquidity support must cover the approved cohort or issuance window. |
| Review staffing | Operator-backed claim review must be staffed for the active issuance window. | Operator-backed claim review must be staffed for the active issuance window. |
| Public terms | Published pricing, benefit, exclusion, and evidence truth must stay aligned. | Published pricing, benefit, exclusion, sponsor, and evidence truth must stay aligned. |
| Metadata/schema | Shared public evidence schema and launch metadata must remain consistent. | Shared public evidence schema and launch metadata must remain consistent. |
Pause conditions
Issuance should pause when:
- posted reserve no longer covers the marketed issuance window
- claims operator or oracle staffing falls below required Phase 0 review readiness
- published schema, pricing, benefit, or evidence truth drifts from launch metadata
- sponsor-backed issuance is described without explicit sponsor or backstop support
- marketing language starts implying broad insurance availability instead of bounded launch availability
Reader checklist
| Reader | Check before proceeding |
|---|---|
| Member | The protection window is active, the SKU fits the event, and the evidence expectations are clear. |
| Sponsor | The cohort lane, reserve source, review readiness, and published terms are explicit. |
| Builder | Public SDK work stays devnet-first unless OmegaX announces mainnet availability. |
| Operator | Product availability, reserve truth, and staffing readiness are aligned before issuance stays open. |